Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients

Cancer Letters

Volumn 250, Issue 2, 2007, Pages 213-219

  Luron, Lionel ^a   Avril, Marie Françoise ^b   Sarasin, Alain ^a   Daya Grosjean, Leela ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

HPV; Non melanoma skin cancer; Squamous cell carcinoma; UV; Xeroderma pigmentosum

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARCINOGENESIS; CHILD; DISEASE ASSOCIATION; DNA REPAIR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CARCINOMA; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA REPAIR; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREVALENCE; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM;

HUMAN PAPILLOMAVIRUS;

EID: 34047189773     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.10.008     Document Type: Article

References (32)

1. Kraemer K.H., Lee M.M., and Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol. 123 (1987) 241-250
2. Daya-Grosjean L., and Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat. Res. 571 (2005) 43-56
3. Nishigori C., Yarosh D.B., Donawho C., and Kripke M.L. The immune system in ultraviolet carcinogenesis. J. Invest. Dermatol. Symp. Proc. 1 (1996) 143-146
4. Norris P.G., Limb G.A., Hamblin A.S., Lehmann A.R., Arlett C.F., Cole J., Waugh A.P., and Hawk J.L. Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy. J. Invest. Dermatol. 94 (1990) 94-100
5. Gaspari A.A., Fleisher T.A., and Kraemer K.H. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J. Clin. Invest. 92 (1993) 1135-1142
6. Suzuki H., Kalair W., Shivji G.M., Wang B., Toto P., Amerio P., Kraemer K.H., and Sauder D.N. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J. Invest. Dermatol. 117 (2001) 1151-1155
7. Majewski S., and Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch. Dermatol. 131 (1995) 1312-1318
8. Jong-Tieben L.M., Berkhout R.J., Smits H.L., Bouwes Bavinck J.N., Vermeer B.J., van der Woude F.J., and ter Schegget J. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J. Invest. Dermatol. 105 (1995) 367-371
9. Berkhout R.J., Bouwes Bavinck J.N., and ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J. Clin. Microbiol. 38 (2000) 2087-2096
10. Bouwes Bavinck J.N., Feltkamp M., Struijk L., and ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J. Investig. Dermatol. Symp. Proc. 6 (2001) 207-211
11. Harwood C.A., and Proby C.M. Human papillomaviruses and non-melanoma skin cancer. Curr. Opin. Infect. Dis. 15 (2002) 101-114
12. Sterling J.C. Human papillomaviruses and skin cancer. J. Clin. Virol. 32 Suppl. 1 (2005) S67-S71
13. Couve-Privat S., Bouadjar B., Avril M.F., Sarasin A., and Daya-Grosjean L. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res. 62 (2002) 7186-7189
14. Berkhout R.J., Tieben L.M., Smits H.L., Bavinck J.N., Vermeer B.J., and ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol. 33 (1995) 690-695
15. Harwood C.A., Spink P.J., Surentheran T., Leigh I.M., De Villiers E.M., McGregor J.M., Proby C.M., and Breuer J. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J. Clin. Microbiol. 37 (1999) 3545-3555
16. Shamanin V., Delius H., and De Villiers E.M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J. Gen. Virol. 75 Pt. 5 (1994) 1149-1156
17. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Brocker T.R., and Wohnsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7 (1989) 209-214
18. Snijders P.J., van den Brule A.J., Schrijnemakers H.F., Snow G., Meijer C.J., and Walboomers J.M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol. 71 Pt 1 (1990) 173-181
19. Harwood C.A., Surentheran T., McGregor J.M., Spink P.J., Leigh I.M., Breuer J., and Proby C.M. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J. Med. Virol. 61 (2000) 289-297
20. Meyer T., Arndt R., Christophers E., Nindl I., and Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect. Prev. 25 (2001) 533-547
21. Forslund O., Ly H., Reid C., and Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br. J. Dermatol. 149 (2003) 64-73
22. Iftner A., Klug S.J., Garbe C., Blum A., Stancu A., Wilczynski S.P., and Iftner T. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res. 63 (2003) 7515-7519
23. Stockfleth E., Nindl I., Sterry W., Ulrich C., Schmook T., and Meyer T. Human papillomaviruses in transplant-associated skin cancers. Dermatol. Surg. 30 (2004) 604-609
24. Harwood C.A., Surentheran T., Sasieni P., Proby C.M., Bordea C., Leigh I.M., Wojnarowska F., Breuer J., and McGregor J.M. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br. J. Dermatol. 150 (2004) 949-957
25. Forslund O., Lindelof B., Hradil E., Nordin P., Stenquist B., Kirnbauer R., Slupetzky K., and Dillner J. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in stripped biopsies from the same tumors. J. Invest. Dermatol. 123 (2004) 388-394
26. Antonsson A., Karanfilovska S., Lindqvist P.G., and Hansson B.G. General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol. 41 (2003) 2509-2514
27. Termorshuizen F., Feltkamp M.C., Struijk L., de Gruijl F.R., Bavinck J.N., and van Loveren H. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J. Invest. Dermatol. 122 (2004) 1456-1462
28. Jackson S., and Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19 (2000) 592-598
29. Jackson S., Ghali L., Harwood C., and Storey A. Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus. Br. J. Cancer 87 (2002) 319-323
30. Akgul B., Karle P., Adam M., Fuchs P.G., and Pfister H.J. Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. Virology 308 (2003) 279-290
31. Akgul B., Lemme W., Garcia-Escudero R., Storey A., and Pfister H.J. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch.Virol. 150 (2005) 145-151
32. Purdie K.J., Surentheran T., Sterling J.C., Bell L., McGregor J.M., Proby C.M., Harwood C.A., and Breuer J. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J. Invest. Dermatol. 125 (2005) 98-107